The certification, issued September 24, 2026, follows an independent assessment by Amtivo (USA) Inc. While the company has long adhered to FDA regulations, this new status formalizes their approach to risk management, process control, and documentation. For clinicians, the move provides a layer of assurance that the surgical tools utilized in implant procedures are manufactured under a strict, audited framework.

Alan Banks, President of GuidedSMILE, noted that the certification distinguishes the firm in a sector where independent quality assessment remains uncommon. By moving beyond internal protocols to a standardized, three-year certification cycle, the company aims to bolster the reliability of its digital-to-operatory systems. The standard covers the entire lifecycle of their products, ensuring that as GuidedSMILE expands its portfolio of guided solutions, the underlying production processes remain subject to annual performance evaluations.